Medical - Devices industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
76 of 151
P/E 22.9 vs period average 26.1 Cheaper than its history
Ranked among 53 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/53 | ![]() | $12.98 | 16.9 | 93 | 68 | 98 | 100 |
| 2/53 | ![]() | $74.19 | 19.1 | 86 | 76 | 94 | 99 |
| 3/53 | ![]() | $15.91 | — | 56 | 73 | 95 | 99 |
| 4/53 | ![]() | $83.03 | 32.7 | 36 | 74 | 96 | 98 |
| 5/53 | ![]() | $78.18 | 23.1 | 63 | 73 | 77 | 98 |
| 6/53 | ![]() | $14.90 | 12.2 | 96 | 3 | 89 | 97 |
| 7/53 | ![]() | $73.00 | 16.1 | 66 | 66 | 93 | 97 |
| 8/53 | ![]() | $22.40 | 20.9 | 84 | 52 | 91 | 94 |
| 9/53 | ![]() | $102.69 | 49.4 | 46 | 19 | 90 | 92 |
| 10/53 | ![]() | $317.73 | 77.9 | 15 | 72 | 84 | 92 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $10B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $21B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.2% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks